Showing results (1-10 of 390) with videos related to
Sort By:
Pageof 39
Cancer Treatment Reports|May 1, 1983
Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouseR T Dorr, D S AlbertsMedical Oncology and Tumor Pharmacotherapy|January 1, 1988
Quantitation of ellipsoid tumor areas using a circumferential measuring deviceR T Dorr, D S AlbertsJournal of the National Cancer Institute|January 1, 1985
Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouseR T Dorr, D S AlbertsCancer Treatment Reports|November 1, 1981
Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compoundsR T Dorr, D S AlbertsBritish Journal of Cancer|January 1, 1982
Cimetidine enhancement of cyclophosphamide antitumour activityR T Dorr, D S AlbertsOncology Nursing Forum|May 1, 1991
Case report: topical DMSO for mitomycin-C-induced skin ulcerationD S Alberts, R T DorrCancer|August 15, 1992
Topical absorption and inactivation of cytotoxic anticancer agents in vitroR T Dorr, D S AlbertsInvestigational New Drugs|January 1, 1983
Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluentsR T Dorr, D S AlbertsCancer Research|June 1, 1981
Modulation of experimental doxorubicin skin toxicity by beta-adrenergic compoundsR T Dorr, D S AlbertsCancer Chemotherapy and Pharmacology|January 1, 1986
Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantroneR T Dorr, D S Alberts, M SoblePageof 39